Recently, 69 patients with heterozygous Transcription Factor 20 (TCF20) gene variants were described as showing predominant developmental delay with variable intellectual and behavioral abnormalities (DDVIBA) (MIM#618430) [1,2] and less frequently, poorly delineated movement disorders.